Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 65 sources its claims cite is checked for support yet.

A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation

Open access

Abstract

Optic neuropathies, including glaucoma, are characterized by the progressive degeneration of retinal ganglion cells (RGCs), ultimately leading to irreversible vision loss. Increasing evidence implicates microglia, the resident immune cells of the central nervous system, as key modulators of RGC health and disease progression. However, the precise mechanisms by which microglia influence RGCs remain poorly understood, particularly in the human context. In this study, we established human pluripotent stem cell-derived coculture systems incorporating microglia, astrocytes, and RGCs to explore how microglia shape RGC growth and maturation under physiological conditions. We first examined the impact of homeostatic microglia on RGCs in both coculture and triculture systems, revealing distinct influences of cell types in coculture compared to when they were grown individually. We then modeled inflammatory states by activating microglia with lipopolysaccharide and evaluated their effects on RGCs both directly and in the context of astrocyte coculture. This stepwise, reductionist approach enabled us to dissect the cellular interactions driving RGC vulnerability in inflammatory conditions relevant to optic neuropathies. Our findings provide insight into the complex neuroimmune landscape that underlies RGC degeneration and identify key pathways that may serve as therapeutic targets across a range of optic nerve diseases.

Overview

CoChat Summary

TL;DR

The authors developed hPSC-derived co- and tri-culture systems of microglia, astrocytes, and retinal ganglion cells (RGCs) to model homeostatic and LPS-induced neuroinflammatory interactions. They report that homeostatic microglia enhance RGC maturation, whereas LPS-activated microglia, especially with astrocytes, drive RGC degeneration and pro-inflammatory transcriptional programs.

Key findings

  • hPSC-derived microglia co-cultured with RGCs for 3 weeks enhanced RGC morphology—increased soma size, neurite length, and neurite complexity by Sholl analysis—and increased electrophysiological activity by multielectrode array, including mean firing rate and burst frequency, compared with RGCs alone.
  • In tri-culture (RGC:microglia:astrocyte 5:1:2) for 1 week, all three cell types showed enhanced morphological maturation versus monoculture; scRNA-seq showed tri-culture RGCs upregulated maturation markers (NEFL, RBPMS, SYN1) and axonal growth/excitability genes, while monoculture RGCs expressed higher developmental genes (VSX2, RAX, ATOH7, SIX6).
  • LPS (150 ng/ml, 24 h) activated hPSC-derived microglia, increasing MHC-II/CD74 expression, pro-inflammatory cytokine secretion by MSD V-Plex, and phagocytosis of pHrodo Zymosan-Red at all time points; LPS-activated microglia co-cultured with RGCs for 3 weeks reduced RGC soma size, neurite length, primary neurite number, mean firing rate, and burst frequency/percentage.
  • In tri-culture with LPS every 48 h, RGC viability decreased at 1 week and further at 3 weeks, with retracted RGC morphology, reactive astrocytes (increased soma area, reduced branch length), and amoeboid microglia; scRNA-seq showed pro-inflammatory upregulation of RGC neuroinflammation/stress genes (CCL2, ADAM17, SPP1, SQSTM1, CTSD, TIGAR), astrocyte inflammatory/complement genes (CXCL10, CCL3, CXCL1, C1QA/C1QC/C1R), and microglial inflammatory/complement genes, while control microglia expressed homeostatic markers (P2RY12, CX3CR1, INPP5D, CSF1R).

Methods

  • hPSC lines WTC-11 and H7 were differentiated into microglia-like cells via hematopoietic progenitors, astrocytes via a neural progenitor protocol, and RGCs from Brn3b-tdTomato-Thy1.2 retinal organoids followed by MACS sorting against Thy1.2.
  • Co-cultures used RGC:microglia at 5:1; tri-cultures used RGC:microglia:astrocyte at 5:1:2. Microglia were activated with LPS (150 ng/ml) for 24 h or every 48 h for sustained activation; assays included immunocytochemistry, qRT-PCR, MSD V-Plex proinflammatory panel, pHrodo Zymosan phagocytosis, multielectrode array, and scRNA-seq (10x Chromium/NovaSeq 6000; GEO accession GSE308054).
  • Statistics used Student’s t-test or one-way ANOVA with Tukey post-hoc at p < 0.05; scRNA-seq differential expression used the Wilcoxon rank-sum test with p < 0.05.

Limitations

  • Stated in the paper: the 2D co-/tri-culture systems do not fully recapitulate the in vivo retinal microenvironment; future 3D microphysiological systems such as retinal organoids and microfluidic platforms are needed.
  • Stated in the paper: cellular ratios were selected from prior studies to support survival and reproducible crosstalk, not to replicate in vivo abundance; a single native ratio is difficult to define because glial abundance differs between retina and optic nerve head/optic nerve. Current limitations also included loss of RGCs prior to functional maturation in organoids and reduced control over cell number, timing, and cell-type ratios, necessitating 2D platforms.
  • Stated in the paper: LPS was used as a standard pro-inflammatory stimulus, but comprehensive comparison of activation paradigms was beyond scope; TNFα activation was only proof-of-concept. The OPTN(E50K) mutation did not produce significantly greater degeneration than control RGCs in the presence of LPS-stimulated microglia, likely because the robust neurotoxic effect of activated microglia masked additional vulnerability. Evident from the text: the study relies on in vitro morphological, functional, and scRNA-seq readouts without in vivo validation or direct mechanistic perturbation of the identified pathways.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2522958123

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 1 Not valid · 31 Not checked · 67 Own results and interpretations

54 more claims

Create a free account to see all 99 claims and to verify the 56 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 72 references

Research works printed but not linked: 1

  1. J. Harkin Data from “A human pluripotent stem cell tri-culture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation” NCBI Gene Expression Omnibus. Available at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308054. Deposited 15 September 2025. · doi:10.1101/2025.07.01.662573

Cited by

See all 3

Metadata

Authors
Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S.
Affiliations
Indiana University Indianapolis (US)
Corresponding author
Meyer, Jason S.
Venue
Proceedings of the National Academy of Sciences
Published
2026-08-19
Volume
123
Issue
34
Pages
e2522958123-e2522958123
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4412024286
Cited by
3
References
72
Citations by year
2026: 3
FWCI
5.12
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • PubMed (submittedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
Funders
  • HHS | NIH | National Eye Institute (R01EY033022, U24EY033269)
  • Gilbert Family Foundation (923016)
  • BrightFocus Foundation (G2020369, G2022003F)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords
retinal ganglion cells, microglia, neuroinflammation, optic neuropathy, glaucoma, human pluripotent stem cells, triculture, astrocytes, lipopolysaccharide, microglial activation, neuroimmune interactions, optic nerve diseases
MeSH terms
Neuroinflammatory Diseases, Astrocytes, Humans, Inflammation, Lipopolysaccharides, Retinal Ganglion Cells, Microglia, Coculture Techniques, Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation. https://app.cochat.ai/papers/10.1073/pnas.2522958123
The paper
Harkin, J., Gomes, C., Afify, R., Patil, S. V., Hetzer, S. M., Tutrow, K. D., Peña, K. H., Baker, A., Lavekar, S. S., Huang, K.-C., & Meyer, J. S. (2026). A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2522958123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.